Researcher
Ilse Vaneycken
- Keywords:Medicine
- Disciplines:Other translational sciences not elsewhere classified, Other basic sciences not elsewhere classified, Human and medical genetics not elsewhere classified, Other clinical sciences not elsewhere classified
Affiliations
- Nuclear Medicine (Department)
Member
From1 Oct 2011 → Today - Medical Imaging (Research group)
Member
From1 Jan 2011 → Today - Supporting clinical sciences (Department)
Member
From15 Apr 2022 → Today - Faculty of Medicine and Pharmacy (Faculty)
Member
From22 Jun 2017 → 7 Sep 2017 - Supporting clinical sciences (Department)
Member
From1 Jan 2014 → 31 Mar 2018 - Medical Imaging and Physical Sciences (Department)
Member
From1 Oct 2007 → 31 Dec 2013
Projects
1 - 1 of 1
- Molecular imaging of HER2 expression of breast carcinoma with radiolabeled NanobodiesFrom1 Jan 2009 → 31 Dec 2010Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 19
- Phase II Trial Assessing the Repeatability and Tumor Uptake of [68Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast Carcinoma(2024)
Authors: Odrade Gondry, Vicky Caveliers, Catarina Xavier, Marian Vanhoeij, Guy Verfaillie, Christel Fontaine, Katrien Glorieus, Jacques De Grève, Sofie Joris, Ine Luyten, et al.
Pages: 178-184 - Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)(2023)
Authors: Odrade Gondry, Catarina Xavier, Laurens Raes, Johannes Heemskerk, Nick Devoogdt, Hendrik Everaert, Karine Breckpot, Quentin Lecocq, Lore Decoster, Christel Fontaine, et al.
Pages: 1378-1384 - Lyophilization of NOTA-sdAbs(2021)
Authors: Henri Vincent Baudhuin, Pieter-Jan Van Bockstal, Thomas De Beer, Ilse Vaneycken, Jessica Bridoux, Geert Raes, Vicky Caveliers, Marleen Keyaerts, Nick Devoogdt, Tony Lahoutte, et al.
Pages: 194-204 - Phase I trial of 131I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients(2021)
Authors: Matthias D'Huyvetter, Jens De Vos, Vicky Caveliers, Ilse Vaneycken, Johannes Heemskerk, Francois P Duhoux, Christel Fontaine, Marian Vanhoeij, Albert D Windhorst, Frank Van Der Aa, et al.
Pages: 1097-1105 - Clinical Translation of [68Ga]Ga-NOTA-anti-MMR-sdAb for PET/CT Imaging of Protumorigenic Macrophages(2019)
Authors: Catarina Xavier, Anneleen Blykers, Damya Laoui, Evangelia Bolli, Ilse Vaneycken, Jessica Bridoux, Henri Vincent Baudhuin, Geert Raes, Hendrik Everaert, Kiavash Movahedi, et al.
Pages: 898-906 - (18)F-nanobody for PET imaging of HER2 overexpressing tumors(2016)
Authors: Catarina Xavier, Anneleen Blykers, Ilse Vaneycken, Matthias D'Huyvetter, Johannes Heemskerk, Tony Lahoutte, Nick Devoogdt, Vicky Caveliers
Pages: 247-52 - Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma(2016)
Authors: Marleen Keyaerts, Catarina Xavier, Johannes Heemskerk, Nick Devoogdt, Hendrik Everaert, Chloé Ackaert, Marian Vanhoeij, Francois P Duhoux, Thierry Gevaert, Pascal Simon, et al.
Pages: 27-33 - PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments(2015)
Authors: Anneleen Blykers, Steve Joël Marie-José Schoonooghe, Catarina Xavier, Kevin D'Hoe, Damya Laoui, Matthias D'Huyvetter, Ilse Vaneycken, Frederik Cleeren, Guy Bormans, Johannes Heemskerk, et al.
Pages: 1265-1271 - Synthesis, preclinical validation, dosimetry and toxicity of 68Ga-NOTA-Anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer(2013)
Authors: Catarina Xavier, Ilse Vaneycken, Johannes Heemskerk
Pages: 776-784 - Synthesis, preclinical validation and toxicology of 68Ga-NOTA-Anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer(2012)
Authors: Catarina Xavier, Ilse Vaneycken, Johannes Heemskerk